ArticleEvaluation of ADAM28 expression in adult Egyptian Acute Myeloid Leukemia patients and its impact on outcome
ArticleEvaluation of ADAM28 expression in adult Egyptian Acute Myeloid Leukemia patients and its impact on outcome
ArticleCLINICAL RELEVANCE OF RUNX1 MUTATION IN PRIMARY REFRACTORY EGYPTIAN ACUTE MYELOID LEUKEMIA PATIENTS.
ArticleCLINICAL RELEVANCE OF RUNX1 MUTATION IN PRIMARY REFRACTORY EGYPTIAN ACUTE MYELOID LEUKEMIA PATIENTS.
ArticleClinical Significance of NPM1 A and Non A Mutations and Its Relation to The ARF/P53 Pathway in Egyptian Acute Myeloid Leukemia Patients
ArticleClinical Significance of NPM1 A and Non A Mutations and Its Relation to The ARF/P53 Pathway in Egyptian Acute Myeloid Leukemia Patients
ArticleIL‑17F and IL- 23 gene polymorphism in patients with acute myeloid leukemia, an Egyptian study
ArticleIL‑17F and IL- 23 gene polymorphism in patients with acute myeloid leukemia, an Egyptian study
ArticleRole of miR-155 expression in acute myeloid leukemia and correlation with nucleophosmin 1 (NPM1) mutations modyfied
ArticleRole of miR-155 expression in acute myeloid leukemia and correlation with nucleophosmin 1 (NPM1) mutations modyfied
ArticleProm-1 (Cd 133) Overexpression in Adult Acute Lymphoblastic Leukemia Egyptian Patients and Relation to Outcome
ArticleProm-1 (Cd 133) Overexpression in Adult Acute Lymphoblastic Leukemia Egyptian Patients and Relation to Outcome
ArticleThe Prognostic Role of Β-Catenin Subcellular Localization in Hepatocellular Carcinoma of Egyptian Patients
ArticleThe Prognostic Role of Β-Catenin Subcellular Localization in Hepatocellular Carcinoma of Egyptian Patients